Transcranial doppler re-screening of subjects who participated in STOP and STOP II

American Journal of Hematology

Volumn 91, Issue 12, 2016, Pages 1191-1194

  Adams, Robert J ^a   Lackland, Dan T ^a   Brown, Lynette ^b   Brown, David ^a   Voeks, Jenifer ^a   Fullerton, Heather J ^c   Kanter, Julie ^a   Kwiatkowski, Janet L ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Tidelands Health Cancer Service   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN ISCHEMIA; CHILD; CLINICAL PROTOCOL; CLINICAL STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY (TOPIC); PATIENT PARTICIPATION; PRIORITY JOURNAL; RESCREENING; RISK ASSESSMENT; RISK REDUCTION; SICKLE CELL ANEMIA; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; YOUNG ADULT; BLOOD FLOW VELOCITY; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; MASS SCREENING; MULTICENTER STUDY; PRESCHOOL CHILD; PROCEDURES; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; STROKE;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; GUIDELINE ADHERENCE; HUMANS; MASS SCREENING; RISK ASSESSMENT; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84995602558     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24551     Document Type: Article

References (22)

1. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605–610.
2. Adams R, McKie V, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med 1998;339:5–11.
3. Adams R, Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 2005;353:2769–2778.
4. Adams RJ, McKie VC, Brambilla DJ, et al. Stroke prevention trial in sickle cell anemia (“STOP”): Study design. Control Clin Trials 1997;19:110–129.
5. McCarville M, Goodin G, Fortner G, et al. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer 2008; 50:818–821.
6. Enninful-Eghan H, Moore R, Ichord R, et al. Transcranial doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr 2010;157:479–484.
7. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2010;117:1130–1140.
8. Fullerton H. Declining stroke rates in Californian children with sickle cell disease. Blood 2004; 104:336–339.
9. George MG, Tong X, Kulina EV, Labarthe DR. Trends in stroke hospitalizations and risk factors among children and young adults, 1995–2008. Ann Neurol 2011; 70:713–721.
10. Ovbiagele B, Adams R. Trends in comorbid sickle cell disease among stroke patients. J Neurol Sci 2012;313:86–91.
11. McCavit T, Xuan L, Zhang S, et al. National trends in incidence rates of hospitalization for stroke in children with sickle cell disease. Pediatr Blood Cancer 2012; 60:823–827.
12. Lehman L, Fullerton H. Changing ethnic disparity in ischemic stroke mortality in US children after the STOP trial. JAMA Pediatr 2013;167:754.
13. Fullerton H, Gardner M, Adams R, et al. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology 2006;67:1098–1099.
14. Bollinger L, Nire K, Rhodes M, et al. Caregivers’ perspectives on barriers to transcranial doppler screening in children with sickle-cell disease. Pediatr Blood Cancer 2010;56:99–102.
15. Goldstein L, Adams R, Alberts M, et al. American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Co-sponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Stroke 2011;42:517–584.
16. The Management of Sickle Cell Disease. National Institute Of Health Web site. www.nhlbi.nih.gov/health-pro/guidelines/current/management-sickle-cell-disease Published 1984. Revised 1989, 1995, and June 2002.
17. Raphael J, Shetty P, Liu H, et al. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality. Pediatr Blood Cancer 2008;51:647–651.
18. Eckrich M, Wang W, Yang E, et al. Adherence to transcranial Doppler screening guidelines among children with sickle cell disease. Pediatr Blood Cancer 2013;60:270–274.
19. Reeves SL, Madden B, Freed GL, Dombkowski KJ. Transcranial doppler screening among children and adolescents with sickle cell anemia. JAMA Pediatr 2016;170:550–556.
20. National Library of Medicine. Department of Health and Human Services [Internet]. 2015 [cited 2015 Sep 5]; Available from: http://www.nlm.nih.gov/od/bor/913BORMinutes.pdf
21. Ware RE, Davis BR, Schultz WH, et al. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial. Lancet 2016;387:661–670.
22. Adams R, Brambilla DJ, Granger S, et al. Stroke and conversion to high risk in children screened with transcranial doppler ultrasound during the STOP Study. Blood 2004;103:3689–3694.